fluorodeoxyglucose f18 has been researched along with cyclin d1 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebihara, A; Goya, T; Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Orikasa, H; Uno, K; Watanabe, K; Yamazaki, K | 1 |
Fu, Z; Han, A; Mu, D; Sun, X; Yang, W; Yu, J; Zhang, Y | 1 |
Honndorf, V; Kukuk, D; Mannheim, JG; Mueller, A; Pichler, BJ; Reischl, G; Röse, L; von Ahsen, O; Wiehr, S | 1 |
Meyer, HJ; Surov, A; Wienke, A | 1 |
1 review(s) available for fluorodeoxyglucose f18 and cyclin d1
Article | Year |
---|---|
Standardized Uptake Values Derived from
Topics: B7-H1 Antigen; Cyclin D1; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Lung Neoplasms; Microvessels; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53 | 2018 |
1 trial(s) available for fluorodeoxyglucose f18 and cyclin d1
Article | Year |
---|---|
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
2 other study(ies) available for fluorodeoxyglucose f18 and cyclin d1
Article | Year |
---|---|
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Cyclin D1; Female; Fluorodeoxyglucose F18; Genes, Tumor Suppressor; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Suppressor Protein p53 | 2006 |
Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Cyclin D1; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2013 |